Skip to content

APOTHEEK CURAVIT: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

APOTHEEK CURAVIT

BE 0461.551.932
NACE 47.730, Retail sale of pharmaceutical products
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
€90,082
2024 · €88,763+€1,319
Equity
€339,890
2024 · €309,808+€30,082
Cash
€116,659
2024 · €100,686+€15,973
Balance sheet total
€700,757
2024 · €668,717+€32,040

Largest movements

2024 to 2025
Assets
  • Receivables within one year +€30,298

    up €30,298 (+33.0%), from €91,794 to €122,092

    of which Trade receivables: +€27,701

  • Tangible fixed assets -€27,430

    down €27,430 (-10.4%), from €262,974 to €235,544

    of which Land and buildings: -€14,500

  • Stocks and contracts +€19,518

    up €19,518 (+11.8%), from €164,741 to €184,260

  • Cash +€15,973

    up €15,973 (+15.9%), from €100,686 to €116,659

    mainly Net result for the year (+€90,082) and Depreciation (+€33,570)

Equity and liabilities
  • Debts after one year -€30,244

    down €30,244 (-15.3%), from €197,680 to €167,436

  • Profit (loss) carried forward +€30,082

    up €30,082 (+10.0%), from €301,414 to €331,496

  • Trade debts +€22,622

    up €22,622 (+34.6%), from €65,431 to €88,053

  • Tax, wage and social debts +€8,911

    up €8,911 (+151%), from €5,905 to €14,816

    of which Remuneration and social security: +€7,527

Income statement
  • Gross operating margin +€20,108

    up €20,108 (+8.6%), from €234,051 to €254,159

  • Staff costs +€19,072

    up €19,072 (+20.4%), from €93,543 to €112,615

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €88,763
Gross operating margin +€20,108
Staff costs -€19,072
Depreciation +€384
Other operating charges -€5
Financial income +€65
Financial charges +€602
Taxes -€762
Result 2025 €90,082
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€106,821
Investment -€1,140
Financing -€89,708
Cash 2024 €100,686
Net result for the year +€90,082
Depreciation +€33,570
Stocks and contracts -€19,518
Receivables within one year -€30,298
Deferred charges and accrued income +€1,320
Trade debts +€22,622
Tax, wage and social debts +€8,911
Other debts +€132
Investment in fixed assets (net) -€1,140
Debts after one year -€30,244
Current portion of long-term debt +€536
Contributions, distributions and other -€60,000
Cash 2025 €116,659
brings cash intakes cash out
Every line side by side 48 lines
Line Code 2024 2025 Change %
Total assets 20/58 €668,717 €700,757 +€32,040 +4.8%
Fixed assets 21/28 €299,364 €266,934 -€32,430 -10.8%
Intangible fixed assets 21 €35,151 €30,151 -€5,000 -14.2%
Tangible fixed assets 22/27 €262,974 €235,544 -€27,430 -10.4%
Land and buildings 22 €159,500 €145,000 -€14,500 -9.1%
Plant, machinery and equipment 23 €98,617 €86,507 -€12,110 -12.3%
Furniture and vehicles 24 €4,857 €4,037 -€820 -16.9%
Financial fixed assets 28 €1,239 €1,239 = 0.0%
Current assets 29/58 €369,353 €433,823 +€64,469 +17.5%
Stocks and contracts in progress 3 €164,741 €184,260 +€19,518 +11.8%
Stocks 30/36 €164,741 €184,260 +€19,518 +11.8%
Amounts receivable within one year 40/41 €91,794 €122,092 +€30,298 +33.0%
Trade receivables 40 €86,748 €114,448 +€27,701 +31.9%
Other amounts receivable 41 €5,047 €7,644 +€2,597 +51.5%
Cash at bank and in hand 54/58 €100,686 €116,659 +€15,973 +15.9%
Deferred charges and accrued income 490/1 €12,132 €10,812 -€1,320 -10.9%
Total equity and liabilities 10/49 €668,717 €700,757 +€32,040 +4.8%
Equity 10/15 €309,808 €339,890 +€30,082 +9.7%
Contributions 10/11 €6,205 €6,205 = 0.0%
Reserves 13 €2,189 €2,189 = 0.0%
Non-distributable reserves 130/1 €1,859 €1,859 = 0.0%
Reserves not available under the articles 1311 €1,859 €1,859 = 0.0%
Tax-exempt reserves 132 €329 €329 = 0.0%
Profit (loss) carried forward 14 €301,414 €331,496 +€30,082 +10.0%
Amounts payable 17/49 €358,909 €360,866 +€1,957 +0.5%
Amounts payable after more than one year 17 €197,680 €167,436 -€30,244 -15.3%
Financial debts 170/4 €197,680 €167,436 -€30,244 -15.3%
Amounts payable within one year 42/48 €161,229 €193,431 +€32,201 +20.0%
Current portion of amounts payable after more than one year 42 €29,708 €30,244 +€536 +1.8%
Trade debts 44 €65,431 €88,053 +€22,622 +34.6%
Suppliers 440/4 €65,431 €88,053 +€22,622 +34.6%
Taxes, remuneration and social security 45 €5,905 €14,816 +€8,911 +151%
Taxes 450/3 €5,905 €7,289 +€1,384 +23.4%
Remuneration and social security 454/9 - €7,527 +€7,527
Other amounts payable 47/48 €60,185 €60,317 +€132 +0.2%
Remuneration, social security and pensions 62 €93,543 €112,615 +€19,072 +20.4%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €33,953 €33,570 -€384 -1.1%
Other operating charges 640/8 €203 €208 +€5 +2.3%
Gross operating margin 9900 €234,051 €254,159 +€20,108 +8.6%
Operating profit (loss) 9901 €106,352 €107,766 +€1,414 +1.3%
Financial income 75/76B €18 €82 +€65 +359%
Recurring financial income 75 €18 €82 +€65 +359%
Financial charges 65/66B €7,470 €6,868 -€602 -8.1%
Recurring financial charges 65 €7,470 €6,868 -€602 -8.1%
Profit (loss) for the period before taxes 9903 €98,900 €100,981 +€2,081 +2.1%
Income taxes 67/77 €10,137 €10,898 +€762 +7.5%
Profit (loss) for the period 9904 €88,763 €90,082 +€1,319 +1.5%
Profit (loss) for the period to be appropriated 9905 €88,763 €90,082 +€1,319 +1.5%

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 28 October 2026 via checked.be.